Market Research Logo

Obio Pharmaceutical Holdings Limited – Product Pipeline Review – H2 2011

23 Pages Global Markets Direct December 14, 2011 SKU: GMD6723903

Obio Pharmaceutical Holdings Limited - Product Pipeline Review - H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Obio Pharmaceutical Holdings Limited - Product Pipeline Review - H2 2011” provides data on the Obio Pharmaceutical Holdings Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Obio Pharmaceutical Holdings Limited’s corporate website, SEC filings, investor presentations and featured press releases, both from Obio Pharmaceutical Holdings Limited and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • Obio Pharmaceutical Holdings Limited - Brief Obio Pharmaceutical Holdings Limited overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Obio Pharmaceutical Holdings Limited human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Obio Pharmaceutical Holdings Limited with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Obio Pharmaceutical Holdings Limited’s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Evaluate Obio Pharmaceutical Holdings Limited’s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Obio Pharmaceutical Holdings Limited in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Obio Pharmaceutical Holdings Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Obio Pharmaceutical Holdings Limited.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Obio Pharmaceutical Holdings Limited and identify potential opportunities in those areas.

Show Full Description


Show Table of Contents



Obio Pharmaceutical Holdings Limited – Product Pipeline Review – H2 2011

Global Markets Direct
December 14, 2011

Search inside this report



Pricing & Delivery

Online Download
$500
Global Site License
$1,500

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report